Cancer
Cancer Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

UTX-TGR-205-2b

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgk

Trial overview

Disease
Blood cancer treatment and diagnosis – TBC
Topic
UTX-TGR-205-2b
Description
This research study will evaluate the safety and efficacy of a study drug called TGR-1202 in combination with another study drug called ublituximab compared to TGR-1202 alone as a possible treatment for Diffuse Large B-cell Lymphoma (DLBCL).
Physicians

Dr. Troy H. Guthrie, Jr.

MD

Medical Oncologist

Works at 2 centers.